Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mindfulness Added to Pharmacological Treatment for Chronic Pain
NCT04859374Unknown
- Sponsor
- Carlo Besta Neurological Institute
- Start
- Sep 2021
- Primary completion
- May 2022
01
Overview
Open-label trial (2 arms), sponsored by Carlo Besta Neurological Institute. Primary endpoint: Change of pain intensity at 12 months. Status: unknown.
Beyond the preview
Go deeper on NCT04859374.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04859374.